Preventive effect of the microalga Chlamydomonas debaryana on the acute phase of experimental colitis in rats
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel diseases (IBD) are characterised by chronic uncontrolled inflammation of intestinal mucosa. Diet and nutritional factors have emerged as possible interventions for IBD. Microalgae are rich sources of n-3 PUFA and derived oxylipins. Oxylipins are lipid mediators involved in the resolution of many inflammatory disorders. The aim of the present study was to investigate the effects of the oxylipin-containing biomass of the microalga Chlamydomonas debaryana and its major oxylipin constituent, (9 Z,11 E,13 S,15 Z)-13-hydroxyoctadeca-9,11,15-trienoic acid ((13 S)-HOTE), on acute 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in rats. Lyophilised microalgal biomass and (13 S)-HOTE were administered by oral route 48, 24 and 1 h before the induction of colitis and 24 h later, and the rats were killed after 48 h. The treatment with the lyophilised microalga and (13 S)-HOTE improved body-weight loss and colon shortening, as well as attenuated the extent of colonic damage and increased mucus production. Cellular neutrophil infiltration, with the subsequent increase in myeloperoxidase levels induced by TNBS, were also reduced after the administration of the lyophilised microalga or (13 S)-HOTE. The anti-inflammatory effects of these treatments were confirmed by the inhibition of colonic TNF-α production. Moreover, lyophilised microalga or (13S)-HOTE down-regulated cyclo-oxygenase-2 and inducible nitric oxide synthase expression. The present study was the first to show the prophylactic effects of a lyophilised biomass sample of the microalga C. debaryana and the oxylipin (13 S)-HOTE on TNBS-induced acute colitis in rats. Our findings suggest that the microalga C. debaryana or derived oxylipins could be used as nutraceuticals in the treatment of the active phase of IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996 · cited 1×
“By contrast, during the resolution of the inflammatory response, a number of anti-inflammatory and pro-resolving lipid mediators are released to promote tissue healing and clearance of micro-organisms and apoptotic cells (6) .”
Heazlewood, C. K., Cook, M. C., Eri, R., Price, G. R., Tauro, S. B., Taupin, D., Thornton, D. J., Png, C. W., Crockford, T. L., Cornall, R. J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050054 · Cited by 701 · cited 1×
“Individuals with CD or ulcerative colitis have been shown to have decreased numbers of goblet cells and reduced mucus thickness (34) .”
Innovative natural functional ingredients from microalgae
Plaza, M., Herrero, M., Cifuentes, A., & Ibáñez, E. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf901070g · Cited by 509 · cited 1×
“Microalgae have been proposed as an interesting natural source in the search for novel bioactive compounds and functional food products((24)).”
Background
Cited by
Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer
Talero, E., García-Mauriño, S., Ávila-Román, J., Rodríguez-Luna, A., Alcaide, A., & Motilva, V. (2015) · Marine Drugs · doi:10.3390/md13106152 · Cited by 255
Self-citationBioactive compounds from microalgae: Current development and prospects
Fu, W., Nelson, D. R., Yi, Z., Xu, M., Khraiwesh, B., Jijakli, K., Chaiboonchoe, A., Alzahmi, A., Al-Khairy, D., Brynjolfsson, S., et al. (2017) · Studies in natural products chemistry · doi:10.1016/b978-0-444-63929-5.00006-1 · Cited by 121
Unlocking the health potential of microalgae as sustainable sources of bioactive compounds
Saide, A., Martínez, K. A., Ianora, A., & Lauritano, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094383 · Cited by 105
“An oxylipin-containing lyophilised (OLM) biomass, where the major oxylipin constituent was (9Z,11E,13S,15Z)-13-hydroxyoctadeca-9,11,15-trienoic acid ((13S)HOTE), from Chlamydomonas debaryana had anti-inflammatory activities on a recurrent 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis mice model [175].”
BackgroundInfluentialEffects of the microalgae Chlamydomonas on gastrointestinal health
Fields, F. J., Lejzerowicz, F., Schroeder, D., Ngoi, S. M., Tran, M., McDonald, D., Jiang, L., Chang, J. T., Knight, R., & Mayfield, S. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103738 · Cited by 104
Andrade, A. D., Hort, M. A., Schimith, L. E., Peraza, G. G., Maria, L. D. S., Soares, M. C. F., Giroldo, D., & Muccillo-Baisch, A. L. (2021) · Acta Scientiarum. Biological Sciences · doi:10.4025/actascibiolsci.v43i1.52889 · Cited by 3
Metadata
- Authors
- Ávila-Román, J., Talero, E., Alcaide, A., Reyes, C. D. L., Zubía, E., García-Mauriño, S., & Motilva, V.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2014-09-05
- Volume
- 112
- Issue
- 7
- Pages
- 1055-1064
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W2031227121
- Cited by
- 27
- References
- 4
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preventive effect of the microalga Chlamydomonas debaryana on the acute phase of experimental colitis in rats. https://app.cochat.ai/papers/10.1017/s0007114514001895
- The paper
- Ávila-Román, J., Talero, E., Alcaide, A., Reyes, C. D. L., Zubía, E., García-Mauriño, S., & Motilva, V. (2014). Preventive effect of the microalga Chlamydomonas debaryana on the acute phase of experimental colitis in rats. British Journal of Nutrition. https://doi.org/10.1017/s0007114514001895
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.